XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash Flows from Operating Activities:    
Net loss $ (2,074,109) $ (1,449,913)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and intangible asset amortization expense 23,042 29,360
Amortization of debt discounts on convertible notes 32,957 1,003,591
Amortization of original issue discount on notes payable 20,163 40,806
(Gain) loss on change in derivative liability (218,715) 286,297
Compensation paid in equity 391,969 4,028
Provision for doubtful accounts 44,127
Gain on sale of assets other 1,850
Loss on extinguishment of debt 415,000
Changes in operating assets and liabilities:    
Accounts and note receivable (101,530) (627,804)
Inventory 164,312 428,733
Prepaid expenses (87,595) 44,405
Accounts payable and accrued liabilities 188,320 (590,724)
Deferred revenue (724,463) 683,505
Accrued interest (9,602) 189,713
Deferred compensation (25,600)
Other liabilities (2,213)
Cash (used in) provided by operating activities (1,980,251) 60,161
Cash Flows From Investing Activities:    
Cash disbursed for patent fees (19,431) (3,813)
Purchase of property and equipment (5,832) (15,126)
Proceeds from the sale of property and equipment 31,000
Cash disbursed for note receivable (20,000)
Cash received from repayment of note receivable 157,218 50,000
Cash provided by investing activities 131,955 42,061
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options 358
Cash proceeds from sale of common stock and warrants 2,685,000
Payments on convertible notes payable (270,000)
Proceeds from issuance of notes payable 500,000
Payments on loans (34,115)
Payments on loans from shareholders (33,178) (96,168)
Cash provided by (used in) financing activities 2,881,822 (129,925)
Net change in cash and cash equivalents 1,033,526 (27,703)
Cash and cash equivalents, beginning of period 319,546 330,557
Cash and cash equivalents, end of period 1,353,072 302,854
Supplemental cash flow information:    
Interest paid
Income tax paid
Non-cash investing and financing activities:    
Conversions of promissory notes and accrued interest to common stock 639,155 889,905
Derivative liability on convertible promissory notes and warrants $ 673,050